TITLE:
Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043)

CONDITION:
Aspergillosis

INTERVENTION:
caspofungin acetate

SUMMARY:

      This study is an open label, noncomparative study using an investigational agent for the
      treatment of documented Candida or Aspergillus infections in pediatric patients (ages 3
      months-17 years).
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 3 Months to 17 Years
Criteria:

        -  Children, 3 months through 17 years of age,

          -  with esophageal candidiasis or

          -  invasive candidiasis or

          -  children requiring salvage treatment of invasive aspergillosis.
      
